- Pressemitteilung BoxID 514473
21-Year-Old College Student Literally Dances Her Heart Out
Dancer Mia Welch Bridged to Heart Transplant with SynCardia Total Artificial Heart http://www.syncardia.com
"During our summer showcase, every time I did a dance, I was exhausted, which wasn't normal for me," said Mia. "I had to walk around with my arms above my head, taking deep breaths. I was having a lot of pain in the right side of my ribs and it wasn't going away. I figured it was just a muscle pull."
A week later, when the pain hadn't subsided, Mia went to the emergency room, but was turned away after being told "an ER is for life and death situations."
A few weeks later, the pain had worsened, her appetite had disappeared and she could only sleep sitting upright. After a visit to a different emergency room, a CAT scan revealed that her heart was enlarged.
"I was in the hospital room by myself when my doctor came in and told me that my heart was failing," said Mia. "It was the scariest thing I've ever heard... I thought, 'I'm going to die.'"
Mia's doctors immediately put her on medication hoping to reverse her heart failure because of her young age. However, over the next two months, Mia's 5'5, 150-pound frame had shrunk by 50 pounds. In February 2011, she developed blood clots in her kidneys and was placed on blood thinners. That June, she was implanted with a defibrillator.
In October 2011, Mia had a right heart catheterization done to check the pressures in her heart. The results showed Mia's heart had further deteriorated and she was admitted to the hospital. The doctors told her mother they needed to find her a donor heart by the next day, or else she would need a left ventricular assist device (LVAD) or the SynCardia temporary Total Artificial Heart to survive.
On Nov. 1, 2011, doctors removed Mia's dying heart and replaced it with the Total Artificial Heart.
"It was scary because everything happened so fast, but I started feeling so much better," said Mia. "I went from really pale to having color in my cheeks again. My blood was moving, I could think straight."
By late November, Mia was using the hospital's Dance Dance Revolution video game every day for an hour.
On Dec. 14, 2011, she was switched from the 400-pound "Big Blue" hospital driver that powered her Total Artificial Heart to the 13.5-pound Freedom® portable driver. With the Freedom driver, Mia was able to start practicing ballet again.
A few months later, on March 17, 2012, Mia was sitting in her hospital room with her boyfriend Corey when she saw a helicopter go past her window. She joked to him that it was her donor heart. Two hours later, her surgeon Dr. Francisco Arabia came in and told her they'd found a match for her.
"It's amazing how fast I recovered from my heart transplant," said Mia. "I left the hospital just nine days after the surgery. I'm very happy I had the Total Artificial Heart before I received my heart transplant because it made me so strong and healthy. If I'd just gone from my failing heart to a donor heart, it would've been a lot harder."
The Freedom portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart. The Freedom driver is CE approved for use in Europe and undergoing an Investigational Device Exemption (IDE) clinical study in the U.S. More than 80 patients worldwide have been supported by the Freedom driver, accounting for more than 30 patient years of support.
Über SynCardia Systems Inc
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE approved Total Artificial Heart. Similar to a heart transplant, the SynCardia temporary Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers and does not require expensive anti-rejection medication, which can cause subsequent complications.
Originally used as a permanent replacement heart, SynCardia’s Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 1,000 implants of the Total Artificial Heart, accounting for more than 250 patient years of life. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles.
SynCardia Ranked #20 Among World’s 50 Most Innovative Companies:
In March 2011, Fast Company magazine ranked SynCardia #20 in its annual list of the world’s 50 Most Innovative Companies for “giving mobility to artificial heart recipients.” Weighing 13.5 lbs, SynCardia’s Freedom® portable driver is the world’s first wearable driver designed to power the Total Artificial Heart both in side and outside the hospital. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
For additional information, please visit: http://www.syncardia.com
Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn
Diese Pressemitteilungen könnten Sie auch interessieren
Shiatsu Massage im Büro für entspanntes Arbeiten
, Medizintechnik, arcotec Mobilfunktechnik GmbH
Dieser Chefsessel oder Bürostuhl mit integrierter Shiatsu-Massage ist der ideale Beitrag zu einer gesunden und wohl tuenden Sitzgelegenheit bei der Schreibtisch-...
Hypothermie-Kostenrechner als Service von 3M
, Medizintechnik, 3M Deutschland GmbH
Mit einer individuellen Risiko- und Kosten-Analyse zum Patienten-Wärmemanagement bietet 3M Medica interessierten Krankenhäusern ab sofort einen neuen, unentgeltlichen...
Optische Fasern für die Leistungsübertragung und Medizintechnik
, Medizintechnik, LASER COMPONENTS GmbH
Analytik, Medizin, Luftfahrt, Militär, Industrie, Telekommunikation oder Industrie-Kommunikation - für jedes Gebiet gibt es eine ideale Großkernfaser mit Stufenindex-Profil...

